FREDUN PHARMACEUTICALS
Back to Balance Sheet
|
FREDUN PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹167 Cr | ₹140 Cr | ₹74 Cr | ₹86 Cr | ₹86 Cr |
What is the latest Total Current Liabilities ratio of FREDUN PHARMACEUTICALS ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹167 Cr |
Mar2023 | ₹140 Cr |
Mar2022 | ₹74 Cr |
Mar2021 | ₹86 Cr |
Mar2020 | ₹86 Cr |
How is Total Current Liabilities of FREDUN PHARMACEUTICALS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹167 Cr | 19.46 | |
Mar2023 | ₹140 Cr | 89.36 | |
Mar2022 | ₹74 Cr | -14.70 | |
Mar2021 | ₹86 Cr | 0.54 | |
Mar2020 | ₹86 Cr | - |
Compare Total Current Liabilities of peers of FREDUN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FREDUN PHARMACEUTICALS | ₹382.6 Cr | 0.4% | 11.6% | -6.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,788.0 Cr | -0.6% | 0.8% | 10.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,283.0 Cr | 3.1% | 3.8% | 49.2% | Stock Analytics | |
CIPLA | ₹121,853.0 Cr | 0.4% | 2.5% | 1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,914.0 Cr | -0.2% | 6.4% | 20.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,932.0 Cr | -0.6% | 3.3% | 0.1% | Stock Analytics |
FREDUN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FREDUN PHARMACEUTICALS | 0.4% |
11.6% |
-6.6% |
SENSEX | -0.6% |
3.1% |
5.3% |
You may also like the below Video Courses